NCT07067021

Brief Summary

General anesthesia has a range of effects that can lead to gastrointestinal (GI) system dysfunctions in the postoperative period. These effects are linked to various factors, from the pharmacological properties of anesthetic agents to neurohumoral effects triggered by surgical stress. Commonly encountered GI dysfunctions include nausea and vomiting, abdominal distension due to decreased intestinal peristalsis and the postoperative inflammatory response, delayed gastric emptying, ileus, fatigue, and delayed initiation of oral feeding. These conditions can prolong hospital stay, increase treatment costs, and reduce patient comfort. In clinical practice, protecting GI function and preventing complications after general anesthesia are of great importance. One of the main goals of applying Enhanced Recovery After Surgery (ERAS) protocols is to reduce the surgical stress response, thereby promoting rapid recovery and improving GI functions. Postoperative gastrointestinal (GI) dysfunction after cesarean section is a common complication that negatively impacts the recovery process. This condition manifests with symptoms such as abdominal pain, nausea, vomiting, and an inability to pass flatus, and it can prolong hospital stay and increase costs. Opioid analgesics are known to negatively affect postoperative GI motility, and regional anesthesia techniques can alleviate these problems by reducing opioid requirements. Fascial plane blocks like the TAP block are thought to reduce somatic and visceral pain by injecting local anesthetics between the deep and superficial layers of the fascia, and may positively influence GI functions through sympathetic blockade. This study aims to observationally investigate the effect of ultrasound-guided transabdominal plane (TAP) block on postoperative gastrointestinal system (GI) dysfunctions in patients who have undergone cesarean section.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2025

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 4, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 15, 2025

Completed
Last Updated

July 18, 2025

Status Verified

June 1, 2025

Enrollment Period

15 days

First QC Date

July 4, 2025

Last Update Submit

July 15, 2025

Conditions

Keywords

Cesarean SectionTAP BlockGastrointestinal Dysfunction

Outcome Measures

Primary Outcomes (1)

  • PRO-diGI (Patient-Reported Outcome Measure for Gastrointestinal Dysfunction after major abdominal surgery)

    Patients will be asked 15 questions from the PRO-diGI (Patient-Reported Outcome Measure for Gastrointestinal Dysfunction after major abdominal surgery) scale to assess GI dysfunction.The first response option was given the highest score of 4 points, and the last response option was given the lowest score of 0 points. Patients received a maximum score of 60 points when their GI function was in the best condition.

    24. hour, 48. hour, 72. hour

Secondary Outcomes (1)

  • The Obstetric Quality-of-Recovery score (ObsQoR-11)

    24. hour

Study Arms (2)

Group T: Patients who received a TAP block under general anesthesia.

Group T: This group consists of patients who underwent Cesarean section under general anesthesia and received a Transabdominal Plane (TAP) block during the surgery. The TAP block is a regional anesthetic technique administered for postoperative pain management.

Group C: Patients who did not receive a TAP block.

Group C (Control Group) Description: This group consists of patients who underwent Cesarean section under general anesthesia but did not receive a TAP block during the surgery. This group will receive standard postoperative pain management for comparison with the effects of the TAP block.

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Turkish kohort

You may qualify if:

  • Patients undergoing elective cesarean section surgery under general anesthesia
  • Patients with American Society of Anesthesiologists (ASA) physical status I-II-III
  • Patients able to understand and respond to the Visual Analog Scale (VAS) for pain
  • No history of drug or alcohol addiction
  • No coagulation disorders
  • No anatomical abnormalities of the gastrointestinal system
  • No gastrointestinal motility disorders
  • No previous abdominal surgery
  • No allergies to local anesthetic drugs
  • No history of diabetes mellitus
  • No severe systemic diseases
  • No intraoperative surgical complications (such as bleeding, conversion to open surgery, or organ injury)
  • Successful block achievement (for relevant groups)

You may not qualify if:

  • Patients undergoing emergency cesarean section under general anesthesia
  • Patients with American Society of Anesthesiologists (ASA) physical status IV-V
  • Patients unable to understand the Visual Analog Scale (VAS) for pain (due to cognitive or psychiatric disorders, or mental impairments)
  • Emergency operations
  • Patients with drug or alcohol addiction
  • Coagulation disorders
  • Anatomical abnormalities of the gastrointestinal system
  • Gastrointestinal motility disorders
  • Previous abdominal surgery
  • Allergy to local anesthetic drugs
  • Diabetes mellitus
  • Presence of severe systemic disease
  • Intraoperative surgical complications (such as bleeding, conversion to open surgery, organ injury, etc.)
  • Unsuccessful block placement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elazığ Fethi Sekin City Hospital

Elâzığ, Elâzığ, 23100, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2025

First Posted

July 15, 2025

Study Start

June 15, 2025

Primary Completion

June 30, 2025

Study Completion

July 2, 2025

Last Updated

July 18, 2025

Record last verified: 2025-06

Locations